OTC Drug Testing

Brand Equivalence to Innovation

Ensure monograph compliance to the U.S. Pharmacopoeia (USP) and European Pharmacopeia (Ph. Eur.) by partnering with Avomeen’s industry-leading OTC testing and development lab. With decades of experience in generic drug testing and bioequivalency, our talented and dedicated Ph.D. scientists are uniquely qualified to formulate improved, novel, and National Brand Equivalent (NBE) products in addition to providing indispensable analytical support.

When you’re in the OTC product development stages, get the testing you need from Avomeen’s OTC lab to guarantee you release a stable and safe product to market.